Hoth Therapeutics Inc (NASDAQ:HOTH) has a beta value of 0.58 and has seen 1.06 million shares traded in the last trading session. The company, currently valued at $16.91M, closed the last trade at $1.28 per share which meant it gained $0.05 on the day or 4.49% during that session. The HOTH stock price is -196.87% off its 52-week high price of $3.80 and 54.69% above the 52-week low of $0.58. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.14 million shares traded. The 3-month trading volume is 1.17 million shares.
The consensus among analysts is that Hoth Therapeutics Inc (HOTH) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
Hoth Therapeutics Inc (NASDAQ:HOTH) trade information
Sporting 4.49% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the HOTH stock price touched $1.28 or saw a rise of 11.11%. Year-to-date, Hoth Therapeutics Inc shares have moved 37.63%, while the 5-day performance has seen it change -2.29%. Over the past 30 days, the shares of Hoth Therapeutics Inc (NASDAQ:HOTH) have changed 52.45%. Short interest in the company has seen 56206.0 shares shorted with days to cover at 0.32.
Hoth Therapeutics Inc (HOTH) estimates and forecasts
The company’s shares have gained 61.03% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 27.96% over the past 5 years. Earnings growth for 2025 is a modest 65.62% while over the next 5 years, the company’s earnings are expected to increase by 26.90%.
HOTH Dividends
Hoth Therapeutics Inc is expected to release its next earnings report on 2025-May-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Hoth Therapeutics Inc (NASDAQ:HOTH)’s Major holders
Insiders own 0.50% of the company shares, while shares held by institutions stand at 2.31% with a share float percentage of 2.32%. Investors are also buoyed by the number of investors in a company, with Hoth Therapeutics Inc having a total of 16.0 institutions that hold shares in the company. The top two institutional holders are ARMISTICE CAPITAL, LLC with over 0.21 million shares worth more than $0.19 million. As of 2024-06-30, ARMISTICE CAPITAL, LLC held 3.0976% of shares outstanding.
The other major institutional holder is UBS GROUP AG, with the holding of over 43355.0 shares as of 2024-06-30. The firm’s total holdings are worth over $39409.0 and represent 0.6305% of shares outstanding.
